Background Although intellectual and neurocognitive deficits accompany schizophrenia,
there are inconsistencies in the literature concerning issues of intellectual decline, premorbid …

Background The profile of cortical neuroanatomical abnormalities in schizophrenia is not
fully understood, despite hundreds of published structural brain imaging studies. This study …

The kynurenine pathway (KP) of tryptophan (TRP) catabolism links immune system activation
with neurotransmitter signaling. The KP metabolite kynurenic acid (KYNA) is increased in …

The schizophrenia brain is differentiated from the normal brain by subtle changes, with
significant overlap in measures between normal and disease states. For the past 25 years, …

Elevated pro-inflammatory cytokines exist in both blood and brain of people with schizophrenia
but how this affects molecular indices of the blood–brain barrier (BBB) is unclear. Eight …

Biomarkers have been sought after in the field of schizophrenia research for decades. In
this paper, we discuss some of the concepts around developing biomarkers in an effort to …

Objective: Although brain changes in schizophrenia have been proposed to mirror those
found with advancing age, the trajectory of gray matter and white matter changes during the …

Background Increases in pro-inflammatory cytokines are found in the brain and blood of
people with schizophrenia. However, increased cytokines are not evident in all people with …

Evidence suggests that anomalous mismatch negativity (MMN) in schizophrenia is related
to glutamatergic abnormalities, possibly involving N-methyl-d-aspartate (NMDA) receptors. …

There is increasing clinical and molecular evidence for the role of hormones and specifically
estrogen and its receptor in schizophrenia. A selective estrogen receptor modulator, …